Ned Porter
Faculty Member
Last active: 5/29/2014

Identification of novel autoxidation products of the omega-3 fatty acid eicosapentaenoic acid in vitro and in vivo.

Yin H, Brooks JD, Gao L, Porter NA, Morrow JD
J Biol Chem. 2007 282 (41): 29890-901

PMID: 17711863 · DOI:10.1074/jbc.M703108200

Increased intake of fish oil rich in the omega-3 fatty acids eicosapentaenoic acid (EPA, C20:5 omega-3) and docosahexaenoic acid (DHA, C22:6 omega-3) reduces the incidence of human disorders such as atherosclerotic cardiovascular disease. However, mechanisms that contribute to the beneficial effects of fish oil consumption are poorly understood. Mounting evidence suggests that oxidation products of EPA and DHA may be responsible, at least in part, for these benefits. Previously, we have defined the free radical-induced oxidation of arachidonic acid in vitro and in vivo and have proposed a unified mechanism for its peroxidation. We hypothesize that the oxidation of EPA can be rationally defined but would be predicted to be significantly more complex than arachidonate because of the fact that EPA contains an addition carbon-carbon double bond. Herein, we present, for the first time, a unified mechanism for the peroxidation of EPA. Novel oxidation products were identified employing state-of-the-art mass spectrometric techniques including Ag(+) coordination ionspray and atmospheric pressure chemical ionization mass spectrometry. Predicted compounds detected both in vitro and in vivo included monocylic peroxides, serial cyclic peroxides, bicyclic endoperoxides, and dioxolane-endoperoxides. Systematic study of the peroxidation of EPA provides the basis to examine the role of specific oxidation products as mediators of the biological effects of fish oil.

MeSH Terms (15)

Animals Arachidonic Acid Atherosclerosis Cardiovascular Diseases Eicosapentaenoic Acid Fishes Fish Oils Humans Lipids Mass Spectrometry Mice Mice, Inbred C57BL Models, Chemical Oxygen Peroxidases

Connections (1)

This publication is referenced by other Labnodes entities: